Show simple item record

dc.contributor.authorMontaser, H
dc.contributor.authorPatel, KA
dc.contributor.authorBalboa, D
dc.contributor.authorIbrahim, H
dc.contributor.authorLithovius, V
dc.contributor.authorNäätänen, A
dc.contributor.authorChandra, V
dc.contributor.authorDemir, K
dc.contributor.authorAcar, S
dc.contributor.authorBen-Omran, T
dc.contributor.authorColclough, K
dc.contributor.authorLocke, JM
dc.contributor.authorWakeling, M
dc.contributor.authorLindahl, M
dc.contributor.authorHattersley, A
dc.contributor.authorSaarimäki-Vire, J
dc.contributor.authorOtonkoski, T
dc.date.accessioned2021-03-15T15:14:29Z
dc.date.issued2021-01-26
dc.description.abstractMANF is an endoplasmic reticulum resident protein that plays a crucial role in attenuating ER stress responses. Although MANF is indispensable for the survival and function of mouse beta cells, its precise role in human beta cell development and function is unknown. Herein, we show that lack of MANF in humans results in diabetes due to increased ER stress leading to impaired beta cell function. We identified two patients from different families with childhood diabetes and a neurodevelopmental disorder associated with homozygous loss-of-function mutations in the MANF gene. To study the role of MANF in human beta cell development and function, we knocked out the MANF gene in human embryonic stem cells and differentiated them into pancreatic endocrine cells. Loss of MANF induced mild ER stress and impaired insulin processing capacity of beta cells in vitro Upon implantation to immunocompromised mice, the MANF knockout grafts presented elevated ER stress and functional failure, particularly in diabetic recipients. By describing a new form of monogenic neurodevelopmental diabetes syndrome caused by disturbed ER function, we highlight the importance of adequate ER stress regulation for proper human beta cell function and demonstrate the crucial role of MANF in this process.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipAcademy of Finlanden_GB
dc.description.sponsorshipSigrid Jusélius Foundationen_GB
dc.description.sponsorshipNovo Nordisk Foundationen_GB
dc.description.sponsorshipJDRFen_GB
dc.identifier.citationPublished online 26 January 2021en_GB
dc.identifier.doi10.2337/db20-1174
dc.identifier.grantnumber110082/Z/15/Zen_GB
dc.identifier.grantnumber219606/Z/19/Zen_GB
dc.identifier.grantnumberWT098395/Z/12/Zen_GB
dc.identifier.grantnumber297466en_GB
dc.identifier.grantnumber312437en_GB
dc.identifier.grantnumber2-SRA-2018-496-A-Ben_GB
dc.identifier.urihttp://hdl.handle.net/10871/125135
dc.language.isoenen_GB
dc.publisherAmerican Diabetes Associationen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/33500254en_GB
dc.rights© 2021 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.en_GB
dc.titleLoss of MANF causes childhood onset syndromic diabetes due to increased endoplasmic reticulum stressen_GB
dc.typeArticleen_GB
dc.date.available2021-03-15T15:14:29Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Diabetes Association via the DOI in this recorden_GB
dc.identifier.eissn1939-327X
dc.identifier.journalDiabetesen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021-01-20
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2021-01-26
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-03-15T15:09:59Z
refterms.versionFCDAM
refterms.dateFOA2021-03-15T15:14:34Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record